Know Cancer

or
forgot password

Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer: A Feasibility Study


Phase 1
18 Years
N/A
Not Enrolling
Both
Carcinoma, Non-Small-Cell Lung

Thank you

Trial Information

Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer: A Feasibility Study


Non-small cell lung cancer (NSCLC) is a disease that often presents as an unresectable
tumor. As a result, radiotherapy is the main standard of treatment. Unfortunately,
radiotherapy is limited by several factors, including that the lung can move up to 4 cm
between inspiration and expiration. As a result, a radiation oncologist often has to widen
his treatment field to include for this motion. This leads to greater side effects for the
patient. Two techniques that are being explored to improve the tumor control of
radiotherapy and to minimize side effects to normal tissues in NSCLC treatment include
breath-held gating and tomotherapy. Breath-held gating will allow the investigators to
treat patients at the right moment in their breathing cycle consistently - minimizing the
normal tissue exposed to radiation. In addition, both gated breathing and tomotherapy will
allow the investigators to create a more refined tumor volume treated and exclude more of
the normal tissues. Consequently, they hope these methods will prove to be a better way to
treat patients with non-resectable NSCLC.


Inclusion Criteria:



- Stage I-III NSCLC

- Karnofsky Performance Status (KPS) equal to or greater than 70

- Forced expiratory volume in 1 second (FEV1) equal to or greater than 1.0L

Exclusion Criteria:

- Myocardial infarction (MI) disease

- Recurrent disease

- Complete tumour resection

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

safety and adverse events

Principal Investigator

Wilson Roa, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Alberta Health Services

Authority:

Canada: Health Canada

Study ID:

LU-11-0051 / 21808

NCT ID:

NCT00129012

Start Date:

April 2005

Completion Date:

September 2006

Related Keywords:

  • Carcinoma, Non-Small-Cell Lung
  • radiation therapy
  • carcinoma
  • non-small cell lung
  • Carcinoma
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location